Applied Genetic Technologies (AGTC) Misses Q3 EPS by 4c, Sales Miss

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. AAPL
2. PLTR
3. DOX
4. VRTX
5. CRWD
6. CHKP
7. ON
8. HNGE
9. INSP
10. AMD

Go back to Applied Genetic Technologies (AGTC) Misses Q3 EPS by 4c, Sales Miss

Applied Genetic Technologies (AGTC) Announces New Data on its AAV-Based Gene Therapies for the Treatment of Achromatopsia & X-Linked Retinitis Pigmentosa

May 11, 2017 7:18 AM EDT

Applied Genetic Technologies Corporation (NASDAQ: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announced the presentation of new data from studies in animal models of achromatopsia (ACHM) and X-linked retinitis pigmentosa (XLRP) that support the companys clinical development programs in these indications. The data were presented at the American Society of Gene and Cell Therapy 20th Annual Meeting, taking place in Washington, D.C., May 10-13.

ACHM and XLRP are rare inherited retinal... More